Outcome of myeloablative conditioning and unrelated donor hematopoietic cell transplantation for childhood acute lymphoblastic leukemia in third remission

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 12, 2011, Pages 1833-1840

  Nemecek, Eneida R ^a   Ellis, Kristin ^b   He, Wensheng ^b   Bunin, Nancy J ^c   Bajwa, Rajinder S ^d   Cheerva, Alexandra ^e   Cairo, Mitchell S ^f   Dvorak, Christopher ^g   Duval, Michel ^h   Davies, Stella ⁱ   Eapen, Mary ^b   Gross, Thomas G ^d   Hussein, Ayad A ^j   MacMillan, Margaret L ^k   Mehta, Parinda A ⁱ   Pulsipher, Michael A ^l   Seber, Adriana ^m   Woolfrey, Ann E ⁿ   Frangoul, Haydar A ^o   Carpenter, Paul A ⁿ  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CENTER FOR INTERNATIONAL BLOOD AND MARROW TRANSPLANT RESEARCH   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

^e KOSAIR CHILDREN'S HOSPITAL   (United States)

^f Department of Medicine   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF MONTREAL   (Canada)

ⁱ CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^j KING HUSSEIN CANCER CENTER   (Jordan)

^k UNIVERSITY OF MINNESOTA MEDICAL CENTER   (United States)

^l PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^m Institute of Pediatric Oncology   (Brazil)

ⁿ Fred Hutchinson Cancer Research Center   (United States)

^o VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

Advanced ALL; BMT; HCT; Nonrelapse mortality

Indexed keywords

ALEMTUZUMAB; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; MELPHALAN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER MORTALITY; CHILD; CHILDHOOD LEUKEMIA; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MYELOABLATIVE CONDITIONING; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; RECURRENCE RISK; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TRANSPLANTATION CONDITIONING; UNRELATED DONORS;

EID: 81255161748     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.05.014     Document Type: Article

References (26)

1. Gaynon P.S., Angiolillo A.L., Carroll W.L., et al. Long-term results of the Children's Cancer Group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report. Leukemia 2010, 24:285-297.
2. Mitchell C., Richards S., Harrison C.J., et al. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia 2010, 24:406-418.
3. Pui C.H., Pei D., Sandlund J.T., et al. Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia 2010, 24:371-382.
4. Tallen G., Ratei R., Mann G., et al. Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90. J Clin Oncol 2010, 28:2339-2347.
5. Eapen M., Raetz E., Zhang M.J., et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006, 107:4961-4967.
6. Borgmann A., von Stackelberg A., Hartmann R., et al. Unrelated donor stem cell transplantation compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission: a matched-pair analysis. Blood 2003, 101:3835-3839.
7. Bunin N., Carston M., Wall D., et al. Unrelated marrow transplantation for children with acute lymphoblastic leukemia in second remission. Blood 2002, 99:3151-3157.
8. Ko R.H., Ji L., Barnette P., et al. Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study. J Clin Oncol 2010, 28:648-654.
9. Woolfrey A.E., Anasetti C., Storer B., et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 2002, 99:2002-2008.
10. Duval M., Klein J.P., He W., et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 2010, 28:3730-3738.
11. Borgmann A., Baumgarten E., Schmid H., et al. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?. Bone Marrow Transplant 1997, 20:939-944.
12. Afify Z., Hunt L., Green A., et al. Factors affecting the outcome of stem cell transplantation from unrelated donors for childhood acute lymphoblastic leukemia in third remission. Bone Marrow Transplant 2005, 35:1041-1047.
13. Gassas A., Ishaqi M.K., Afzal S., Dupuis A., Doyle J. Outcome of haematopoietic stem cell transplantation for paediatric acute lymphoblastic leukaemia in third complete remission: a vital role for graft-versus-host-disease/graft-versus-leukaemia effect in survival. Br J Haematol 2008, 140:86-89.
14. Weisdorf D., Spellman S., Haagenson M., et al. Classification of HLA-matching for retrospective analysis of unrelated donor transplantation: revised definitions to predict survival. Biol Blood Marrow Transplant 2008, 14:748-758.
15. Rowlings P.A., Przepiorka D., Klein J.P., et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997, 97:855-864.
16. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980, 69:204-217.
17. Klein J., Moeschberger M. Survival Analysis: Techniques of Censored and Truncated Data 2003, Springer-Verlag, New York.
18. Lin D.Y. Nonparametric inference for cumulative incidence functions in competing risks studies. Stat Med 1997, 16:901-910.
19. Cox D.R. Regression models and life tables. J R Stat Soc 1972, 34:187-202.
20. Schultz K.R., Pullen D.J., Sather H.N., et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). Blood 2007, 109:926-935.
21. Nachman J.B., La M.K., Hunger S.P., et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the Children's Oncology Group. J Clin Oncol 2009, 27:5189-5194.
22. Balduzzi A., Valsecchi M.G., Uderzo C., et al. Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 2005, 366:635-642.
23. Pulsipher M.A., Boucher K.M., Wall D., et al. Reduced-intensity allogeneic transplantation in pediatric patients ineligible for myeloablative therapy: results of the Pediatric Blood and Marrow Transplant Consortium Study ONC0313. Blood 2009, 114:1429-1436.
24. Verneris M.R., Eapen M., Duerst R., et al. Reduced-intensity conditioning regimens for allogeneic transplantation in children with acute lymphoblastic leukemia. Biol Blood Marrow Transplant 2010, 16:1237-1244.
25. Mohty M., Labopin M., Volin L., et al. Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood 2010, 116:4439-4443.
26. Marks D.I., Wang T., Perez W.S., et al. The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood 2010, 116:366-374.